Acromegaly R&D Pipeline Analysis Report, H2-2018

Acromegaly R&D Pipeline Analysis Report, H2-2018

  • August 2018 •
  • 60 pages •
  • Report ID: 5492605 •
  • Format: PDF
Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies

Acromegaly Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Acromegaly pipeline products.

The Acromegaly pipeline guide presents complete overview of drugs currently being developed for Acromegaly. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Acromegaly pipeline candidate.
Research and Development progress along with latest news related to each of the Acromegaly pipeline candidates is included.

Major companies participating in therapeutic development of Acromegaly are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided.

Amid strong interest for cure of Acromegaly from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Acromegaly clinical and pre clinical products.

The report assists in identifying potential upcoming companies and drugs in Acromegaly pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Information in the report is sourced from our proprietary platform, built through extensive primary and secondary research methodology. Data is presented in user friendly and ready to use format.

Scope of Acromegaly pipeline report includes

Panorama of Acromegaly pipeline markets including statistics on therapeutic drugs and companies involved

Acromegaly Pipeline candidates across various development phases including both pre clinical, discovery and clinical stages are covered

Acromegaly pipeline candidates across various ‘Mechanism of Actions’ are also presented in the study

Overview of companies participating in Acromegaly pipeline with short introduction to their businesses and pipeline projects

For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co developer and licensee are provided.

Research and Development progress and trial details, results wherever available, are also included in the pipeline study

The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Acromegaly pipeline therapeutics

Reasons to Buy
Get clear understanding of the entire Acromegaly pipeline, with details on active projects

Get in detail information of each product with updated information on each project along with key milestones

Know the list of companies participating in global Acromegaly pipeline along with progress of each of the company’s products and information on associations/collaborations/licensing data

Get trial information for each pipeline product under development

Understand the pipeline structure in terms of mechanism of Action, phase and company

Please Note: The report will be delivered in 2 working days after purchase

Our reports have been used by over 10K customers, including:

2231/3m 2231/bio-merieux 2231/bloommedical 2231/innovaderma 2231/lg 2231/medtronic 2231/merck 2231/pfizer 2231/roche 2231/samsung-medison 2231/selecta 2231/seoul-national-university 2231/world-health 2114/canon 2114/pg 2114/samsonite 2114/samsung 2114/seb 2114/siemens 2055/comtech 2055/google 2055/intelsat 2055/microsoft 2055/viacom 2055/visa 2055/warner 2055/yandex 2000/ferrero 2000/dr-schar 2267/3m 2267/air-liquide 2267/basf 2267/beaulieu 2267/bmw 2267/bosh 2267/bouygues 2267/chemistry 2267/essilor 2267/exxon-mobile 2267/general-motors 2267/georgia-pacific 2267/honeywell 2267/kodak 2267/nissan 2267/saint-gobain 2267/shell 2267/siemens 2267/spie 2376/accenture 2376/airbnb 2376/allianz 2376/bcg 2376/deloitte 2376/enac 2376/ing-direct 2376/kpmg 2376/mit 2376/pc 2376/roland-berger 2376/united-states-post 2231/3m 2231/bio-merieux 2231/bloommedical 2231/innovaderma 2231/lg

Related reports and data

Global Wearable Injectors Industry

4780 5450 4251
207 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Wearable Injectors Market to Reach $9.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Wearable Injectors estimated at US$4.8 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at aCAGR of 9.7% over the period 2020-2027. On-Body injectors,...

  • Therapy
  • World
  • Europe
  • China
  • United States

Global Pneumonia Therapeutics Industry

4341 4950 3861
133 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Pneumonia Therapeutics Market to Reach $22.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Pneumonia Therapeutics estimated at US$14.5 Billion in the year 2020, is projected to reach a revised size of US$22.5 Billion by 2027, growing at a CAGR of 6.5% over the analysis period...

  • Therapy
  • World
  • China
  • United States

Global Neuroprotection Therapeutics Industry

4341 4950 3861
182 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Neuroprotection Therapeutics Market to Reach $85.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Neuroprotection Therapeutics estimated at US$53.6 Billion in the year 2020, is projected to reach a revised size of US$85.1 Billion by 2027, growing at a CAGR of 6.8% over the analysis...

  • Therapy
  • World
  • China
  • United States

Global Gout Therapeutics Industry

4911 5600 4368
279 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Gout Therapeutics Market to Reach $9.7 Billion by 2027 - Amid the COVID-19 crisis, the global market for Gout Therapeutics estimated at US$3.7 Billion in the year 2020, is projected to reach a revised size of US$9.7 Billion by 2027, growing at a CAGR of 14.8% over the analysis period 2020-2027....

  • Therapy
  • World
  • China
  • United States

Global Hunter Syndrome Treatment Industry

4911 5600 4368
280 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Hunter Syndrome Treatment Market to Reach $1.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hunter Syndrome Treatment estimated at US$966.6 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at a CAGR of 6.1% over the analysis period...

  • Therapy
  • World
  • China
  • United States

Global Peptide Therapeutics Industry

4780 5450 4251
385 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Peptide Therapeutics Market to Reach $47 Billion by 2027 - Amid the COVID-19 crisis, the global market for Peptide Therapeutics estimated at US$27.2 Billion in the year 2020, is projected to reach a revised size of US$47 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Innovative,...

  • Therapy
  • World
  • China
  • United States

Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Industry

4341 4950 3861
129 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market to Reach $3.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Post-Traumatic Stress Disorder (PTSD) Therapeutics estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.1 Billion by 2027,...

  • Anxiety Disorder
  • Therapy
  • World
  • China
  • United States

Global Systemic Psoriasis Therapeutics Industry

4341 4950 3861
100 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Systemic Psoriasis Therapeutics Market to Reach $19.1 Billion by 2027 - Amid the COVID-19 crisis, the global market for Systemic Psoriasis Therapeutics estimated at US$10.7 Billion in the year 2020, is projected to reach a revised size of US$19.1 Billion by 2027, growing at a CAGR of 8.6% over the...

  • Therapy
  • Autoimmune Disease
  • World
  • China
  • United States

Global Guillain-Barre Syndrome Therapeutics Industry

4341 4950 3861
174 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Guillain-Barre Syndrome Therapeutics Market to Reach $679.6 Million by 2027 - Amid the COVID-19 crisis, the global market for Guillain-Barre Syndrome Therapeutics estimated at US$491.1 Million in the year 2020, is projected to reach a revised size of US$679.6 Million by 2027, growing at a CAGR of...

  • Therapy
  • Neurological Disorder
  • World
  • China
  • United States

Global Breast Cancer Therapeutics Industry

4780 5450 4251
243 pages • By Global Industry Analysts • Apr 2021

Abstract: - Global Breast Cancer Therapeutics Market to Reach $29.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Breast Cancer Therapeutics estimated at US$17.2 Billion in the year 2020, is projected to reach a revised size of US$29.8 Billion by 2027, growing at a CAGR of 8.2% over the analysis...

  • Breast Cancer
  • Therapy
  • World
  • China
  • United States